HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ping-Ping He Selected Research

HLA-C*03:04 antigen

10/2003Association of HLA class I alleles with psoriasis vulgaris in southeastern Chinese Hans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ping-Ping He Research Topics

Disease

23Atherosclerosis
06/2022 - 10/2012
4Cardiovascular Diseases (Cardiovascular Disease)
06/2022 - 01/2019
4Inflammation (Inflammations)
06/2022 - 01/2014
4Neoplasms (Cancer)
01/2020 - 01/2017
2Insulin Resistance
10/2021 - 08/2013
2Hypertension (High Blood Pressure)
10/2021 - 01/2018
2Brain Ischemia (Cerebral Ischemia)
06/2021 - 07/2015
2Neoplasm Metastasis (Metastasis)
08/2018 - 01/2017
2Atherosclerotic Plaque (Atheroma)
12/2017 - 01/2015
1Prostatic Neoplasms (Prostate Cancer)
11/2021
1Necrosis
11/2021
1Brain Diseases (Brain Disorder)
11/2021
1Obesity
10/2021
1Type 2 Diabetes Mellitus (MODY)
10/2021
1Congenital Heart Defects (Congenital Heart Defect)
10/2021
1Heart Failure
10/2021
1Reperfusion Injury
06/2021
1Rupture
01/2021
1Dyslipidemias (Dyslipidemia)
01/2021
1Ventricular Remodeling
01/2021
1Bacteremia
01/2020
1Infections
01/2020
1Coronary Artery Disease (Coronary Atherosclerosis)
12/2015
1Brain Edema (Cerebral Edema)
07/2015
1Vascular Diseases (Vascular Disease)
10/2014
1Weight Gain
08/2013
1Sleep Initiation and Maintenance Disorders (Insomnia)
08/2013
1Vitiligo
12/2005
1Dyschromatosis symmetrica hereditaria 1
06/2004
1Psoriasis (Pustulosis Palmaris et Plantaris)
10/2003
1Ectodermal Dysplasia (Aplasia Cutis Congenita)
06/2003

Drug/Important Bio-Agent (IBA)

10LipidsIBA
06/2022 - 01/2014
7Lipoprotein Lipase (Diacylglycerol Lipase)IBA
05/2018 - 10/2012
7CholesterolIBA
01/2018 - 01/2013
6ApolipoproteinsIBA
12/2017 - 01/2014
6Apolipoproteins E (ApoE)IBA
12/2017 - 01/2014
4CytokinesIBA
01/2019 - 01/2014
4ATP-Binding Cassette Transporters (ABC Transporters)IBA
09/2014 - 01/2013
3Proteins (Proteins, Gene)FDA Link
11/2021 - 12/2014
3Peptides (Polypeptides)IBA
01/2020 - 01/2017
2Oxygen (Dioxygen)IBA
06/2021 - 01/2020
2AntagomirsIBA
06/2021 - 01/2014
2MicroRNAs (MicroRNA)IBA
06/2021 - 01/2018
2Laminin (Merosin)IBA
01/2020 - 01/2017
2LigandsIBA
01/2020 - 01/2017
2Pharmaceutical PreparationsIBA
01/2019 - 01/2017
2Biological ProductsIBA
01/2018 - 12/2014
2HLA Antigens (Human Leukocyte Antigens)IBA
12/2005 - 10/2003
1histone deacetylase 3IBA
06/2022
1LipopolysaccharidesIBA
11/2021
16-methyladenineIBA
10/2021
1Glucose (Dextrose)FDA LinkGeneric
06/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1ResistinIBA
01/2021
1CAP1-6DIBA
01/2021
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1VancomycinFDA LinkGeneric
01/2020
1nobiletinIBA
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2018
1Eosine Yellowish-(YS) (Eosin)IBA
12/2017
1oil red OIBA
12/2017
1Hematoxylin (Haematoxylon)IBA
12/2017
1Histone Deacetylases (Histone Deacetylase)IBA
12/2017
1LuciferasesIBA
12/2017
1pyreneIBA
01/2017
1tyrosyl-isoleucyl-glycyl-seryl-arginineIBA
01/2017
1amyloid beta-protein (16-20)IBA
01/2017
1EnzymesIBA
01/2017
1Biocompatible Materials (Biomaterials)IBA
01/2017
1Histone MethyltransferasesIBA
01/2016
1Neuroprotective AgentsIBA
07/2015
1Interleukin-27 (Interleukin 27)IBA
10/2014
13' Untranslated Regions (3' UTR)IBA
09/2014
1Growth Differentiation Factor 15IBA
02/2014
1Advanced Oxidation Protein Products (AOPP)IBA
01/2014
1Sucrose (Saccharose)IBA
08/2013
1Triglycerides (Triacylglycerol)IBA
08/2013
1N- (2- (5- methoxy- indol- 3- yl)- ethyl)- 4- oxo- 4H- pyran- 2- carboxamideIBA
08/2013
1ApelinIBA
02/2013
1HLA-DQB1 antigen (HLA DQB1)IBA
12/2005
1HLA-DQA1 antigen (HLA DQA1)IBA
12/2005
1Adenosine DeaminaseIBA
06/2004
1RNA (Ribonucleic Acid)IBA
06/2004
1HLA-C*06 antigenIBA
10/2003
1HLA-A Antigens (HLA-A)IBA
10/2003
1HLA-C*03:04 antigenIBA
10/2003
1Connexin 30IBA
06/2003

Therapy/Procedure

1Therapeutics
08/2018
1Intravenous Injections
01/2017
1Ischemic Postconditioning
07/2015